New Mexico Register / Volume XXXIV, Issue 19 / October 10, 2023
This
is an amendment to 16.19.8 NMAC, Section 9, 11, 15, 17, 20, 21 and 22 effective 10/10/2023
Explanatory
paragraph: Subsections B through I of
16.19.8.9 NMAC were not published as there are no changes. Subsections B through D of 16.19.8.11 NMAC
were not published as there are no changes.
Subsections B through H of 16.19.8.15 NMAC were not published as there
are no changes. Subsections B through E of 16.19.8.17 NMAC were not published
as there are no changes. Subsections B
through H of 16.19.8.20 NMAC were not published as there are no changes. Subsections A and B of 16.19.8.21 NMAC were
not published as there are no changes.
16.19.8.9 MINIMUM REQUIRED INFORMATION FOR WHOLESALE DRUG DISTRIBUTION
LICENSURE:
A. Every
wholesale distributor who engages in the wholesale distribution of drugs shall
be licensed with the board by submitting an application
and providing information required by the board on an application approved by
the board including [ but not limited to]:
(1) applicant’s full name; all trade or business names used by the licensee (includes “is doing business as” and “formerly known as”) which cannot be identical to the name used by another unrelated wholesale distributor, third-party logistics provider, or repackager licensed by the board; full business address and telephone number;
(2) type of ownership, e.g. individual, partnership, limited liability company or
corporation;
(3) name(s) of the owner(s) of the applicant, including;
(a) if a person, the name, address, social security number or Federal Employer Identification Number (FEIN), and date of birth;
(b) if other than a person, the name, address, social security number and date of birth of each partner, limited liability company member, or corporate officer and corporate director and the federal employer identification number;
(c) if a corporation, the state of incorporation; and
(d) if a publicly traded corporation, the information in Subparagraph (b) of this paragraph is not required for corporate officers and corporate directors;
(e) any other relevant information that the board requires;
(4) name(s), business address(es), telephone number(s) of a person(s) to serve as the designated representative(s) for each facility of the wholesale distributor that engages in the distribution of drugs;
(5) evidence of criminal background checks and fingerprinting of the applicant, if a person, and of the applicant’s designated representative; the background check shall be sufficient to include all states residence since the person has been an adult;
(6) a list of all state and federal licenses, registrations or permits, including the license, registration or permit numbers issued to the wholesale drug distributor by any other state and federal authority that authorizes the wholesale distributor to purchase, possess and distribute drugs;
(7) a list of all disciplinary actions or any other sanction by state and federal agencies against the wholesale distributor as well as any such actions against principals, owners, directors or officers;
(8) a full description of each facility and warehouse located in New Mexico, including all locations utilized for drug storage or distribution; the description must include the following:
(a) square footage;
(b) security and alarm system descriptions;
(c) terms of lease or ownership;
(d) address and;
(e) temperature and humidity controls;
(9) a description of the wholesale distributor’s drug import and export activities;
(10) a copy of the wholesale distributor’s written policies and procedures as required in Subsection I of 16.19.8.13 NMAC, (Written policies and procedures);
(11) a facility located outside of New Mexico shall submit a copy of a current satisfactory inspection report issued by the FDA, or state licensing authority, or by a third-party inspection service approved by the FDA or the state authority licensing such wholesale distributor, or by the board;
(12) the information collected pursuant to Paragraphs (5), (8) and (10) of this subsection shall be made available only to the board, and to state and federal law enforcement officials; the board shall make provisions for protecting the confidentiality of the information collected under this section.
(13) renewal applications shall be on a form furnished by the
board.
***
[16.19.8.9 NMAC - Rp, 16.19.8.9 NMAC, 11-28-2017; A, 10/10/2023]
16.19.8.11 PERSONNEL: As a condition of receiving and retaining a wholesale drug distributor license, the licensee shall require each person employed in any prescription drug wholesale distribution activity to have education, training, and experience, or any combination thereof, sufficient for that person to perform the assigned functions in such a manner as to provide assurance that the drug product quality, safety and security will at all times be maintained by law. Each person that is issued an initial or renewal license as a wholesale distributor whether in state or out of state must designate in writing on a form required by the board a person for each facility to serve as the designated representatives of the wholesale distributor.
A. To be certified as a designated representative a person must:
(1) submit an application on a form furnished by the board and
provide information that includes [but is not limited to]:
(a) evidence of criminal background check and fingerprinting, the background check shall be sufficient to include all states residence since the person has been an adult;
(b) date of birth and social security number;
(c) occupations, positions of employment and offices held during the past seven years;
(d) whether the person during the past seven years has been enjoined, either temporarily or permanently, by a court of competent jurisdiction from violating and state or federal laws regulating the possession, control or wholesale distribution of prescription drugs or devices, together with details of such events;
(e) whether the person has been during the past seven years, the subject of any proceeding for the revocation of any professional or business license or any criminal violation and if so, the nature of the proceeding and the disposition of the proceeding;
(f) description of any involvement by the person with any business, including any investments, other than the ownership of stock in a publicly traded company or mutual fund during the past seven years, which manufactured, administered, prescribed, wholesale distributed or stored prescription drugs and devices in which such businesses were names as a party in a lawsuit;
(g) description of any criminal offense (not including minor traffic violations) of which the person, as an adult, was found guilty, regardless of whether adjudication of guilt was withheld or whether the person pled guilty or nolo contendere; if the person indicates that a criminal conviction is under appeal and submits a copy of the notice of appeal of the criminal offense, the applicant must, within 15 days after the disposition of the appeal, submit to the board a copy of the final written order of disposition; and
(h) any other information the board deems relevant;
(2) may serve as the designated representative for only one wholesale distributor at any one time, except where more than one licensed wholesale distributor is co-located in the same facility and such wholesale distributors are members of an affiliated group as defined in Section 1504 of the Internal Revenue Code;
(3) be actively involved in and aware of the actual daily operations, purchasing and inventory control of the wholesale distributor;
(a) employed full-time in a managerial position by the wholesale distributor;
(b) physically present at the wholesale distributor during normal business hours, except for time periods when absent due to illness, family illness or death, scheduled vacation or other authorized absence;
(c) aware of and knowledgeable about all policies and procedures pertaining to the operations of the wholesale distributor.
***
[16.19.8.11 NMAC - Rp, 16.19.8.11 NMAC, 11-28-2017; A, 10/10/2023]
16.19.8.15 MINIMUM REQUIRED INFORMATION FOR
THIRD-PARTY LOGISTICS PROVIDER LICENSURE:
A. Every third-party logistics provider, located in New
Mexico or located in another state and not licensed as a third-party logistics
provider by the FDA, who engages in third-party logistics activities involving
product shall be licensed with the board, by submitting an
application and providing information required by the board on an
application approved by the board, including [but is not limited to]:
(1) applicant’s full name; all trade or business names used by the licensee (includes “is doing business as” and “formerly known as”), which cannot be identical to the name used by another unrelated wholesale distributor, third-party logistics provider, or repackager licensed by the board; full business address and telephone number;
(2) type of ownership, e.g. individual, partnership, limited liability company or
corporation;
(3) name(s) of the owner(s) of the applicant, including;
(a) if a person, the name, address, social security number or FEIN, and date of birth;
(b) if other than a person, the name, address, social security number and date of birth of each partner, limited liability company member, or corporate officer and corporate director and the federal employer identification number;
(c) if a corporation, the state of incorporation; and
(d) if a publicly traded corporation, the information in Subparagraph (b) of this paragraph is not required for corporate officers and corporate directors.
(e) any other relevant information that the board requires;
(4) name(s), business address(es), telephone number(s) of a person(s) to serve as the designated representative(s) for each facility of the third-party logistics provider that engages in the distribution of drugs;
(5) evidence of criminal background checks and fingerprinting of the applicant, if a person, and of the applicant’s designated representative; the background check shall be sufficient to include all states residence since the person has been an adult;
(6) a list of all state and federal licenses, registrations or permits, including the license,
registration or permit numbers issued to the third-party logistics provider by any other state and federal authority that authorizes the third-party logistics provider to possess and distribute drugs;
(7) a list of all disciplinary actions or any other sanction by state and federal agencies against the third-party logistics provider as well as any such actions against principals, owners, directors or officers;
(8) a full description of each facility and warehouse located in New Mexico, including all locations utilized for drug storage or distribution; the description must include the following:
(a) square footage;
(b) security and alarm system descriptions;
(c) terms of lease or ownership;
(d) address and;
(e) temperature and humidity controls;
(9) a description of the third-party logistics provider’s drug import and export activities;
(10) a copy of the third-party logistics provider’s written policies and procedures as required in Subsection D of 16.19.8.18 NMAC;
(11) a
facility located outside of New Mexico shall submit a copy of a current satisfactory inspection report
issued by the FDA, or state licensing authority, or by a third-party inspection
service approved by the FDA or the state authority licensing such third-party
logistics provider, or by the board;
(12) the information collected pursuant to Paragraphs (5), (8) and (10) of this subsection shall be made available only to the board, and to state and federal law enforcement officials; the board shall make provisions for protecting the confidentiality of the information collected under this section.
(13) renewal applications shall be on a form
furnished by the board.
***
[16.19.8.15 NMAC - Rp, 16.19.8.15 NMAC, 11-28-2017; A,
10/10/2023]
16.19.8.17 PERSONNEL: As a condition of receiving and retaining
a third-party logistics provider license, the licensee shall require each
person employed in any prescription drug third-party logistics activity to have
education, training, and experience, or any combination thereof, sufficient for
that person to perform the assigned functions in such a manner as to provide
assurance that the drug product quality, safety and security will at all times
be maintained by law. Each person that is
issued an initial or renewal license as a third-party-logistics
provider whether in state or out of state must designate in writing on a form
required by the board a person for each facility to serve as the designated
representatives of the third-party logistics provider.
A. To be certified as a designated representative a
person must:
(1) submit an
application on a form furnished by the board and provide information
that includes [but not limited to]:
(a) evidence of criminal background check
and fingerprinting, the background check shall be sufficient to include all
states residence since the person has been an adult;
(b) date of birth and social security
number;
(c) occupations, positions of employment
and offices held during the past seven years;
(d) whether the person during the past
seven years has been enjoined, either temporarily or permanently, by a court of
competent jurisdiction from violating and state or federal laws regulating the
possession, control or wholesale distribution of prescription drugs or devices,
together with details of such events;
(e) whether the person has been during
the past seven years, the subject of any proceeding for the revocation of any
professional or business license or any criminal violation and if so, the
nature of the proceeding and the disposition of the proceeding;
(f) description of any involvement by
the person with any business, including any investments, other than the
ownership of stock in a publicly traded company or mutual fund during the past
seven years, which manufactured, administered, prescribed, distributed or
stored prescription drugs and devices in which such businesses were names as a
party in a lawsuit;
(g) description of any criminal offense
(not including minor traffic violations) of which the person, as an adult, was
found guilty, regardless of whether adjudication of guilt was withheld or
whether the person pled guilty or nolo contendere; if the person indicates that
a criminal conviction is under appeal and submits a copy of the notice of
appeal of the criminal offense, the applicant must, within 15 days after the
disposition of the appeal, submit to the board a copy of the final written
order of disposition;
(h) any other information the board deems
relevant;
(2) may serve as the designated
representative for only one third-party logistics provider at any one time,
except where more than one licensed third-party logistics provider is
co-located in the same facility and such third-party logistics providers are
members of an affiliated group as defined in Section 1504 of the Internal
Revenue Code;
(3) be actively involved in and aware of
the actual daily operations and inventory control of the third-party logistics
provider;
(a) employed full-time in a managerial
position by the third-party logistics provider;
(b) physically present at the third-party
logistics provider during normal business hours, except for time periods when
absent due to illness, family illness or death, scheduled vacation or other
authorized absence;
(c) aware of and knowledgeable about all
policies and procedures pertaining to the operations of the third-party
logistics provider.
***
[16.19.8.17 NMAC - Rp, 16.19.8.17 NMAC, 11-28-2017; A, 10/10/2023]
16.19.8.20 MINIMUM REQUIRED INFORMATION FOR REPACKAGER LICENSURE:
A. Every
repackager who engages in the distribution of product
shall be licensed with the board by submitting an application
and providing information required by the board on an application approved by
the board, including [but not limited to]:
(1) applicant’s full name; all trade or business names used by the licensee (includes “is doing business as” and “formerly known as”), which cannot be identical to the name used by another unrelated wholesale distributor, third-party logistics provider, or repackager licensed by the board; full business address and telephone number;
(2) type of ownership, e.g. individual, partnership, limited liability company or
corporation;
(3) name(s) of the owner(s) of the applicant, including;
(a) if a person, the name, address, social security number or FEIN, and date of birth;
(b) if other than a person, the name, address, social security number and date of birth of each partner, limited liability company member, or corporate officer and corporate director and the federal employer identification number;
(c) if a corporation, the state of incorporation; and
(d) if a publicly traded corporation, the information in Subparagraph (b) of this paragraph is not required for corporate officers and corporate directors.
(e) any other relevant information that the board requires;
(4) name(s), business address(es), telephone number(s) of a person(s) to serve as the designated representative(s) for each facility of the repackager that engages in the distribution of drugs;
[(5) evidence of criminal background checks
and fingerprinting of the applicant, if a person, and of the applicant’s
designated representative; the background check shall be sufficient to include
all states residence since the person has been an adult;]
[(6)]
(5) proof of valid registration as a drug
establishment with the FDA;
[(7)]
(6) a list of all state and federal licenses,
registrations or permits, including the license, registration or permit numbers
issued to the repackager by any other state and
federal authority that authorizes the repackager to
purchase, possess, repackage and distribute drugs;
[(8)]
(7) a list of all disciplinary actions or any
other sanction by state and federal agencies against the repackager
as well as any such actions against principals, owners, directors or officers;
[(9)]
(8) a full description of each facility and
warehouse located in New Mexico, including all locations utilized for drug
storage or distribution; the description must include the following:
(a) square footage;
(b) security and alarm system descriptions;
(c) terms of lease or ownership;
(d) address and;
(e) temperature and humidity controls;
[(10)]
(9) a description of the repackager’s drug import and export activities;
[(11)]
(10) a copy of the repackager’s
written policies and procedures as required in Subsection D of 16.19.8.23 NMAC;
[(12)]
(11) a facility located outside of New
Mexico shall submit a copy of a
current satisfactory inspection report issued by the FDA, or State licensing
authority, or by a third-party inspection service approved by the FDA or the
state authority licensing such repackager, or
by the board.
[(13)] (12) the
information collected pursuant to Paragraphs [(5), (9)] (8) and [(11)]
(10) of this subsection shall be made available only to the board, and
to state and federal law enforcement officials; the board shall make provisions
for protecting the confidentiality of the information collected under this
section.
(13) renewal applications shall be on a form
furnished by the board.
***
[16.19.8.20 NMAC - Rp, 16.19.8.20 NMAC, 11-28-2017; A, 10/10/2023]
16.19.8.21 MINIMUM QUALIFICATIONS:
***
[C. The
board shall consider the results of a criminal and financial background check
and fingerprinting of the applicant and designated representative, to determine
if an applicant or others associated with the ownership, management or
operations of the repackager have committed criminal
acts that would constitute grounds for denial of licensure.]
[D.]
C. The applicant shall provide and attest to a statement
providing a complete disclosure of any past criminal convictions and violations
of the state and federal laws regarding drugs or devices or an affirmation and
attestation that the applicant has not been involved in, or convicted of, any
criminal or prohibited acts.
[E.]
D. The board shall have the right to deny a
license to an applicant if it determines that the granting of such a license
would not be in the public interest.
Public interest considerations shall be based upon factors and
qualifications that are directly related to the protection of the public health
and safety.
[16.19.8.21 NMAC - Rp, 16.19.8.21 NMAC, 11-28-2017; A, 10/10/2023]
16.19.8.22 PERSONNEL: As a condition of receiving and retaining a repackager license, the licensee shall require each person employed in any repackaging or distribution activity to have education, training, and experience, or any combination thereof, sufficient for that person to perform the assigned functions in such a manner as to provide assurance that the drug product quality, safety and security will at all times be maintained by law. Each person that is issued an initial or renewal license as a repackager whether in state or out of state must designate in writing on a form required by the board a person for each facility to serve as the designated representatives of the repackager.
[A. To
be certified as a designated representative a person must:
(1) submit an application on a form furnished by the board and
provide information that includes but is not limited to;
(a) evidence
of criminal background check and fingerprinting, the background check shall be
sufficient to include all states residence since the person has been an adult;
(b) date
of birth and social security number;
(c) occupations,
positions of employment and offices held during the past seven years;
(d) whether
the person during the past seven years has been enjoined, either temporarily or
permanently, by a court of competent jurisdiction from violating and state or
federal laws regulating the manufacturing, possession, control or distribution
of prescription drugs or devices, together with details of such events;
(e) whether
the person has been during the past seven years, the subject of any proceeding
for the revocation of any professional or business license or any criminal
violation and if so, the nature of the proceeding and the disposition of the
proceeding;
(f) description
of any involvement by the person with any business, including any investments,
other than the ownership of stock in a publicly traded company or mutual fund
during the past seven years, which manufactured, administered, prescribed,
distributed or stored prescription drugs and devices in which such businesses
were names as a party in a lawsuit;
(g) description
of any criminal offense (not including minor traffic violations) of which the
person, as an adult, was found guilty, regardless of whether adjudication of
guilt was withheld or whether the person pled guilty or nolo contendere; if the
person indicates that a criminal conviction is under appeal and submits a copy
of the notice of appeal of the criminal offense, the applicant must, within 15
days after the disposition of the appeal, submit to the board a copy of the final
written order of disposition;
(h) any
other information the board deems relevant;
(2) may
serve as the designated representative for only one repackager
at any one time, except where more than one licensed repackager
is co-located in the same facility and such repackagers
are members of an affiliated group as defined in Section 1504 of the Internal
Revenue Code;
(3) be
actively involved in and aware of the actual daily operations, purchasing and
inventory control of the repackager;
(a) employed
full-time in a managerial position by the repackager;
(b) physically
present at the repackager facility during normal
business hours, except for time periods when absent due to illness, family
illness or death, scheduled vacation or other authorized absence;
(c) aware
of and knowledgeable about all policies and procedures pertaining to the
operations of the repackager.
B. The
criminal and financial information collected pursuant to this section shall be
made available only to the board, a third party recognized by the board, and to
state and federal law enforcement officials.
The board and a third party recognized by the board shall make
provisions for protecting the confidentiality of the information collected
under this section.
C.]
A. Each licensed repackager located
outside of this state that distributes prescription drugs in this state shall
designate a registered agent in this state for service of process. Any licensed repackager
that does not so designate a registered agent shall be deemed to have
designated the secretary of state of this state to be its true and lawful
attorney, upon who may be served all legal processes in any action or
proceeding against such licensed repackager growing
out of or arising from such manufacture or distribution. A copy of any such service or process shall
be mailed to such repackager by the board by
certified mail, return receipt requested, postage prepaid, at the address such
licensed repackager has designated on its application
for licensure in this state. If any such
repackager is not licensed in this state, service on
the secretary of state only shall be sufficient service.
[D.]
B. A designated representative must complete training programs
that address applicable state and federal laws and are provided by qualified
in-house specialists, outside counsel or counseling specialists with
capabilities to help ensure compliance.
[16.19.8.22 NMAC - Rp, 16.19.8.22 NMAC, 11-28-2017; A, 10/10/2023]